Hunlicar Group Limited Schedules Board Meeting to Approve Audited Annual Results and Consider Final Dividend
Key Highlights for Investors:
- The board of directors of Hunlicar Group Limited (Stock Code: 3638) will convene a pivotal meeting on Tuesday, 30 June 2026.
- The meeting will take place at the company’s office at 22/F, Sun Hung Kai Centre, 30 Harbour Road, Wan Chai, Hong Kong.
- The primary agenda is to consider and approve the audited annual consolidated final results for the year ended 31 March 2026.
- The Board will also discuss the potential recommendation for payment of a final dividend to shareholders.
Details Investors Should Note:
- The approval and publication of the audited annual results are significant events for shareholders because they provide a complete and final overview of the company’s financial performance for the past financial year. Any material change in results could affect market sentiment and the share price.
- The consideration of a final dividend is potentially price-sensitive. If a dividend is declared, it may boost investor confidence and positively impact the company’s share value. Conversely, the absence of a dividend or a lower-than-expected payout could have a negative effect.
- The announcement specifies the names of the current board members, including executive and independent non-executive directors, highlighting the governance structure in place.
What Investors Should Watch For:
- Investors should closely monitor the publication of the final audited results and any announcement regarding the final dividend after the board meeting. These outcomes can significantly influence trading activity and share price movement.
- The market will evaluate both the company’s financial performance and its dividend policy, which are central to shareholder returns and market valuation.
The company has not released any preliminary figures or dividend proposals at this stage. All eyes will be on the official disclosures following the board meeting scheduled for 30 June 2026.
Disclaimer: The information above is based on the official announcement released by Hunlicar Group Limited and is intended for informational purposes only. Investors are advised to exercise their own judgment and consider seeking advice from professional financial advisors before making investment decisions. Market conditions and company announcements may change, impacting investment value.
Hunlicar集團有限公司將召開董事會會議，審批經審核年度業績及考慮末期股息
投資者重點：
- Hunlicar集團有限公司（股份代號：3638）董事會將於2026年6月30日（星期二）召開重要會議。
- 會議地點為公司辦公室：香港灣仔港灣道30號新鴻基中心22樓。
- 會議主要議程包括審議及批准截至2026年3月31日止年度經審核綜合最終業績。
- 董事會亦會討論建議派發末期股息予股東的可能性。
股東須注意事項：
- 經審核年度業績的批核及公佈對股東極為重要，因為這將全面反映公司上一財政年度的財務表現。如業績有重大變動，或會影響市場情緒及股價。
- 是否派發末期股息屬敏感消息。如有派息，將有機會提升投資者信心並推高公司股價。反之，如不派息或派息金額低於預期，可能對股價構成壓力。
- 公告同時列明現任董事會成員，包括執行董事及獨立非執行董事，反映公司管治架構。
投資者需密切關注：
- 建議投資者緊貼董事會會議後即將公佈的最終經審核業績及任何有關末期股息的消息。這些結果可能對市場走勢及股價有重要影響。
- 市場將關注公司財務表現及股息政策，這兩者均為股東回報及估值的核心。
公司現階段尚未公佈任何初步數字或股息建議。所有焦點將集中在2026年6月30日董事會會議後的正式披露上。
免責聲明：以上資料根據Hunlicar集團有限公司官方公告整理，僅供參考。投資者應自行判斷及考慮尋求專業財務顧問意見，方作任何投資決定。市場情況及公司公告或會變更，影響投資價值。
